The list of growth factors involved in tumor angiogenesis has grown substantially and includes vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), endostatin, ...

Breast cancer, the most common cancer among women, is notorious for its ability to develop resistance to a wide range of treatments, including surgery, chemotherapy, targeted therapies, and ...

In a randomized trial of 110 patients with metastatic renal cell carcinoma, [19] treatment with the anti-VEGF antibody bevacizumab seemed to significantly prolong time to tumor progression. However, ...

Angiogenesis inhibitors showed no increased risk of arterial dissections or aneurysms in metastatic colorectal cancer patients. The study involved 34,733 patients, with 195 cases matched to 1950 ...